BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36546583)

  • 1. 3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy.
    Kapoor R; Sleeman W; Palta J; Weiss E
    J Appl Clin Med Phys; 2023 Mar; 24(3):e13875. PubMed ID: 36546583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.
    Adachi T; Nakamura M; Shintani T; Mitsuyoshi T; Kakino R; Ogata T; Ono T; Tanabe H; Kokubo M; Sakamoto T; Matsuo Y; Mizowaki T
    Med Phys; 2021 Apr; 48(4):1781-1791. PubMed ID: 33576510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
    Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
    Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
    Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
    Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image masking using convolutional networks improves performance classification of radiation pneumonitis for non-small cell lung cancer.
    Kawahara D; Imano N; Nishioka R; Nagata Y
    Phys Eng Sci Med; 2023 Jun; 46(2):767-772. PubMed ID: 36976438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
    Baker R; Han G; Sarangkasiri S; DeMarco M; Turke C; Stevens CW; Dilling TJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):190-5. PubMed ID: 22929858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features.
    Huang Y; Feng A; Lin Y; Gu H; Chen H; Wang H; Shao Y; Duan Y; Zhuo W; Xu Z
    Radiat Oncol; 2022 Nov; 17(1):188. PubMed ID: 36397060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
    Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
    Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
    Sheng L; Zhuang L; Yang J; Zhang D; Chen Y; Zhang J; Wang S; Shan G; Du X; Bai X
    BMC Cancer; 2023 Oct; 23(1):988. PubMed ID: 37848844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.
    Matsuo Y; Shibuya K; Nakamura M; Narabayashi M; Sakanaka K; Ueki N; Miyagi K; Norihisa Y; Mizowaki T; Nagata Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e545-9. PubMed ID: 22436782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
    Jiang W; Song Y; Sun Z; Qiu J; Shi L
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study.
    Yakar M; Etiz D; Metintas M; Ak G; Celik O
    Technol Cancer Res Treat; 2021; 20():15330338211016373. PubMed ID: 33969761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.
    Yu JH; Wang CL; Liu Y; Wang JM; Lv CX; Liu J; Zhang Q; Fu XL; Cai XW
    Cancer Radiother; 2021 Jun; 25(4):323-329. PubMed ID: 33446419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis.
    Kawahara D; Imano N; Nishioka R; Ogawa K; Kimura T; Nakashima T; Iwamoto H; Fujitaka K; Hattori N; Nagata Y
    Sci Rep; 2021 Aug; 11(1):16232. PubMed ID: 34376721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
    Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
    Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
    Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
    Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers.
    Huang BT; Lin PX; Wang Y; Luo LM
    Clin Lung Cancer; 2023 Dec; 24(8):e323-e331.e2. PubMed ID: 37648569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.